Ruxolitinib improves symptoms in patients with disabling pansclerotic morphea
1. In this case series, ruxolitinib was associated with improved inflammatory markers in patients with disabling pansclerotic morphea (DPM). 2. ...
Tag: Ruxolitinib
Ruxolitinib results in improved repigmentation as compared to vehicle-control in nonsegmental vitiligo
1. In comparison to vehicle-control, a greater proportion of patients using ruxolitinib achieved a reduction in facial Vitiligo Area Scoring ...
#VisualAbstract: Ruxolitinib use may be associated with higher incidences of nonmelanoma skin cancers
Click to read this study in the Journal of the American Academy of Dermatology.
#VisualAbstract: Ruxolitinib improved glucocorticoid-refractory chronic graft-versus-host disease
1. Ruxolitinib was shown to significantly improve failure-free survival for glucocorticoid-refractory chronic graft-versus-host disease (GVHD) compared to control therapy. 2. ...
Ruxolitinib improved glucocorticoid-refractory chronic graft-versus-host disease
1. Ruxolitinib was shown to significantly improve failure-free survival for glucocorticoid-refractory chronic graft-versus-host disease (GVHD) compared to control therapy. 2. ...
